# US 2022/0036766 A1 · Methods and systems for simulating deposition of inhaled drug on lungs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0036766 A1
- Document ID: US20220036766A1
- Status: Published application
- Kind: A1
- Application number: 17/289,522
- Filed: 2020-04-24
- Published: 2022-02-03
- Earliest claimed: 2019-04-24
- Assignees: Cipla Limited
- Applicants: Cipla Limited
- Inventors: Nandan KULKARNI; Geena MALHOTRA
- Web page: https://patentgrep.com/patent/US20220036766A1

## CPC

- G01N 15/00: Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G09B 23/32: with moving parts
- G01N 2015/0046: {in gas, e.g. smoke}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G09B: EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS (devices for psychotechnics or for testing reaction times A61B5/16; games, sports, amusements A63; projectors, projector screens G03B)

## Abstract

An apparatus (100), a system (200), and a method (500) for simulating deposition of an inhaled drug on lungs of an individual are disclosed. The apparatus (100) includes a mouth-throat model (102), an inhalation device (104), and a breath simulator (106) connected to the mouth-throat model (102) for dispersing drug and respiration flow respectively in the mouth-throat model (102). The apparatus (100) also includes a controlling unit (108) in communication with the breath simulator (106) and the inhalation device (104) to detect the dispersion of the respiration flow and actuate the inhalation device (104) to disperse the drug. The respiration flow and the drug are uniformly mixed while passing through a mixing unit (110) formed downstream to the mouth-throat model (102) and the breath simulator (106). The mixture is then received by a lung cast model (112) formed downstream to the mixing unit (110) to accommodate deposition of the drug.

## Claims

### Claim 1

An apparatus (100) for simulating deposition of an inhaled drug on lungs of an individual, the apparatus (100) comprising:
a mouth-throat model (102);
an inhalation device (104) connected to the mouth-throat model (102) and adapted to disperse a drug in the mouth-throat model (102);
a breath simulator (106) connected to the mouth-throat model (102) and adapted to disperse a respiration flow in the mouth-throat model (102), wherein the respiration flow is generated based on a respiration profile of the individual;
a controlling unit (108) in communication with the breath simulator (106) and the inhalation device (104) and adapted to:
detect the dispersion of the respiration flow into the mouth-throat model (102); and
actuate the inhalation device (104) to disperse the drug in the mouth-throat model (102), based on the detection;
a mixing unit (110) formed downstream to the mouth-throat model (102) and the breath simulator (106), such that the respiration flow and the drug are uniformly mixed while passing through the mixing unit (110); and
a lung cast model (112) formed downstream to the mixing unit (110) and adapted to receive the mixture to accommodate deposition of the drug.

### Claim 2 (depends on 1)

The apparatus (100) as claimed in claim 1, comprising:
a sensing unit (120) in communication with the inhalation device (104) and adapted to detect at least one respiration parameter of the individual, wherein the at least one respiration parameter is detected when the individual inhales through the inhalation device (104); and
the controlling unit (108) in communication with the sensing unit (120) and adapted to:
generate the respiration profile of the individual, based on the at least one respiration parameter; and
transmit the respiration profile to the breath simulator (106) for generation of the respiration flow.

### Claim 3 (depends on 2)

The apparatus (100) as claimed in claim 2, wherein the at least one respiration parameter comprises a respiration flow rate, a total lung capacity, an effect of temperature, a humidity gradient, and a mucosal layer in lung on respiration.

### Claim 4 (depends on 1)

The apparatus (100) as claimed in claim 1, wherein the lung cast model (112) is formed based on at least one physiological parameter and the respiration profile of the individual.

### Claim 5 (depends on 1)

The apparatus (100) as claimed in claim 1, comprising a flow regulator (114) in communication with the inhalation device (104) and the controlling unit (108), and adapted to regulate a flow rate of the inhaled drug dispersed in the mouth-throat model (102).

### Claim 6 (depends on 1)

The apparatus (100) as claimed in claim 1, comprising a cascade impactor (116) in communication with the lung cast model (112) and the controlling unit (108), and adapted to evaluate parameters associated with the deposition of the drug on the lung cast model (112).

### Claim 7 (depends on 6)

The apparatus (100) as claimed in claim 6, wherein the parameters associated with the deposition comprise at least one of actual consumption of the drug at a particular lung area upon the deposition and a particle size distribution of the respiration flow and the drug.

### Claim 8 (depends on 6)

The apparatus (100) as claimed in claim 6, comprising a vacuum pump (118) adapted to draw the respiration flow and the drug through the cascade impactor (116).

### Claim 9

A system (200) for simulating deposition of an inhaled drug on lungs of an individual, the system (200) comprising:
a sensing unit (120) in communication with an inhalation device (104) and adapted to detect at least one respiration parameter of the individual, wherein the at least one respiration parameter is detected when the individual inhales through the inhalation device (104);
a breath simulator (106) in communication with the sensing unit (120) and adapted to disperse a respiration flow in the mouth-throat model (102), wherein the respiration flow is generated based on the at least one respiration parameter of the individual; and
a controlling unit (108) in communication with the breath simulator (106) and the inhalation device (104) and adapted to:
detect the dispersion of the respiration flow by the breath simulator (106); and
actuate the inhalation device (104) to disperse the drug in the mouth-throat model (102), based on the detection,
wherein the respiration flow and the drug are forwarded towards a lung cast model (112) for deposition of the drug.

### Claim 10 (depends on 9)

The system (200) as claimed in claim 9, comprising a cascade impactor (116) in communication with the lung cast model (112) and the controlling unit (108), and adapted to evaluate parameters associated with the deposition of the drug on the lung cast model (112).

### Claim 11 (depends on 9)

The system (200) as claimed in claim 9, comprising the controlling unit (108) in communication with the sensing unit (120) and adapted to:
receive details relating to the at least one respiration parameter;
generate a respiration profile of the individual, based on the at least one respiration parameter; and
transmit the respiration profile to the breath simulator (106) for generation of the respiration flow.

### Claim 12 (depends on 8)

The system (200) as claimed in claim 8, wherein the at least one respiration parameter comprises a respiration flow rate, a total lung capacity, an effect of temperature, a humidity gradient, and a mucosal layer in lung on respiration.

### Claim 13 (depends on 10)

The system (200) as claimed in claim 10, wherein the parameters associated with the deposition comprising at least one of actual consumption of the drug at a particular lung area upon the deposition and a particle size distribution of the respiration flow and the drug.

### Claim 14

A method (500) for simulating deposition of an inhaled drug on lungs of an individual, the method comprising:
detecting, by a sensing unit (120), at least one respiration parameter of the individual, wherein the at least one respiration parameter is detected when the individual inhales through an inhalation device (104);
dispersing, by a breath simulator (106), a respiration flow in a mouth-throat model (102), wherein the respiration flow is generated based on the at least one respiration parameter of the individual;
detecting, by a controlling unit (108), the dispersion of the respiration flow by the breath simulator (106); and
actuating, by the controlling unit (108), the inhalation device (104) to disperse the drug in the mouth-throat mode (102), and
analyzing, by a lung cast model (112), deposition of the inhaled drug on the lungs of an individual.

### Claim 15 (depends on 14)

The method (50) as claimed in claim 14, comprising evaluating, by a cascade impactor (116), parameters associated with the deposition of the drug on the lung cast model (112).

### Claim 16 (depends on 14)

The method (500) as claimed in claim 14, comprising:
receiving, by the controlling unit (108), details relating to the at least one respiration parameter;
generating, by the controlling unit (108), a respiration profile of the individual, based on the at least one respiration parameter; and
transmitting, by the controlling unit (108), the respiration profile to the breath simulator (106) for generation of the respiration flow.

### Claim 17 (depends on 14)

The method (500) as claimed in claim 14, comprising analyzing, by the lung cast model (112), distribution of the inhaled drug between the lungs of an individual.
